Published in Arch Gen Psychiatry on March 01, 1972
L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. Int J Tryptophan Res (2009) 1.29
The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol (1975) 1.23
The two faces of serotonin in bone biology. J Cell Biol (2010) 1.05
The Link between Thyroid Function and Depression. J Thyroid Res (2011) 0.92
A comparison of an improved o-phthalaldehyde fluorometric method and high pressure liquid chromatography in the determination of brain 5-hydroxyindoles of rats treated with L-tryptophan and p-chlorophenyl-alanine. Br J Pharmacol (1981) 0.89
The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence and a precise algorithm. Int J Neuropsychopharmacol (2016) 0.82
Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine? Neuropsychiatr Dis Treat (2016) 0.78
Hormone treatment of depression. Dialogues Clin Neurosci (2011) 0.77
Gonadal steroids, brain, and behavior: role of context. Dialogues Clin Neurosci (2002) 0.75
The thyroid and the psychiatrist. Br Med J (1977) 0.75
Liothyronine for Depression: A Review and Guidance for Safety Monitoring. Innov Clin Neurosci (2017) 0.75
Mianserin hydrochloride: a novel antidepressant. Br J Psychiatry (1976) 3.92
The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord (1994) 3.15
Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med (1999) 2.72
Plasma concentration of amitriptyline and clinical response. Lancet (1972) 2.44
Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc Natl Acad Sci U S A (1979) 2.43
Prophylactic lithium in affective disorders. Controlled trial. Lancet (1971) 2.32
The biochemistry of affective disorders. Br J Psychiatry (1967) 2.31
Oxytocin induces maternal behavior in virgin female rats. Science (1982) 2.23
Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry (1991) 2.18
Evidence of chaotic mood variation in bipolar disorder. Arch Gen Psychiatry (1995) 2.15
Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene (2009) 1.90
Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry (2001) 1.85
Folate deficiency in depressive illness. Br J Psychiatry (1970) 1.79
Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry (1993) 1.78
Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med (2000) 1.75
Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness. Psychopharmacology (Berl) (1976) 1.68
Hysterectomy, hormones, and behaviour. A prospective study. Lancet (1981) 1.63
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Tryptamine metabolism in depression. Br J Psychiatry (1965) 1.54
Zimelidine: a therapeutic and pharmacokinetic study in depression. Psychopharmacology (Berl) (1979) 1.51
A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch Gen Psychiatry (1981) 1.49
Mood and body weight in a woman with rapid cycling bipolar disorder: a case report. Psychosom Med (1993) 1.48
The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol (2008) 1.43
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours. Oncogene (2010) 1.43
Prophylactic treatment of alcoholism by lithium carbonate. A controlled study. Lancet (1976) 1.40
Continuation therapy with amitriptyline in depression. Br J Psychiatry (1978) 1.38
Effects of thyrotropin-releasing hormone in depression. Lancet (1972) 1.34
Total and free tryptophan concentration in the plasma of depressive patients. Lancet (1973) 1.34
Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry (2002) 1.32
Thyrotropin releasing hormone: enhancement of dopa activity by a hypothalamic hormone. Science (1972) 1.31
Mineral metabolism in affective disorders. Br J Psychiatry (1965) 1.31
Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature (1976) 1.29
Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch Gen Psychiatry (1969) 1.24
Air pollution and its impacts on wheat yield in the Pakistan Punjab. Environ Pollut (1995) 1.22
High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol (2008) 1.21
Abnormalities of indoleamines in affective disorders. Arch Gen Psychiatry (1972) 1.20
Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study. Lancet (1978) 1.19
Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry (1982) 1.19
Double-blind and open prospective studies on lithium prophylaxis in affective disorders. Psychiatr Neurol Neurochir (1974) 1.18
Current concepts of lithium therapy. Br J Hosp Med (1981) 1.18
Noradrenaline, depressive illness, and the action of amitriptyline. Psychopharmacology (Berl) (1977) 1.17
Indoleamines and affective disorders. J Psychiatr Res (1972) 1.14
Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry (1982) 1.13
Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry (1994) 1.13
Oxytocin facilitates the sexual receptivity of estrogen-treated female rats. Neuropeptides (1986) 1.12
Folic acid enhances lithium prophylaxis. J Affect Disord (1986) 1.11
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer (2011) 1.09
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br J Cancer (2012) 1.09
Borderline hypothyroidism and depression. Annu Rev Med (1995) 1.08
Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry (2005) 1.08
Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther (1983) 1.05
Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry (1990) 1.04
Changes in psychological symptoms in women taking oral contraceptives. Br J Psychiatry (1970) 1.04
Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry (1969) 1.04
Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest (2001) 1.02
Neurotensin blocks certain amphetamine-induced behaviours. Nature (1981) 1.02
Oxytocin antiserum delays onset of ovarian steroid-induced maternal behavior. Neuropeptides (1985) 1.01
Neurotensin: central nervous system effects of a hypothalamic peptide. Brain Res (1977) 1.01
Plasma II-hydroxycorticosteroids in affective disorders. Br J Psychiatry (1967) 1.01
Slow-release lithium carbonate. J Clin Pharmacol J New Drugs (1969) 1.00
Tryptophan in the treatment of depression. Lancet (1967) 1.00
Mineral metabolism in mania. Br Med J (1966) 1.00
Platelet 5-hydroxytryptamine accumulation in depressive illness. Clin Chim Acta (1978) 0.99
A survey study of neuropsychiatric complaints in patients with Graves' disease. J Neuropsychiatry Clin Neurosci (1996) 0.99
Neurotensin, a biologically active peptide. Life Sci (1978) 0.99
Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine. Proc Natl Acad Sci U S A (1979) 0.98
Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide. J Rheumatol (1999) 0.98
Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. J Pharmacol Exp Ther (1975) 0.97
Lithium in the prophylaxis of unipolar depression: a review. J R Soc Med (1983) 0.96
Of the muse and moods mundane. Am J Psychiatry (1994) 0.96
Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience (1983) 0.96
Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch Gen Psychiatry (1990) 0.95
The effect of neurotensin on food consumption in the rat. Eur J Pharmacol (1982) 0.95
Oxytocin and vasopressin immunoreactivity in hypothalamic and extrahypothalamic sites in late pregnant and postpartum rats. Neuroendocrinology (1987) 0.94
5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illness. Postgrad Med J (1976) 0.94
Mianserin and lithium in the prophylaxis of depression. Br J Psychiatry (1978) 0.93
A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Br J Psychiatry (1976) 0.93
Serum and red blood cell folate in depression. Acta Psychiatr Scand (1989) 0.93
Clinical hypothyroidism occurring during lithium treatment: two case histories and a review of thyroid function in 19 patients. Am J Psychiatry (1971) 0.93
Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience (1984) 0.92
Plasma magnesium and calcium in depression. Br J Psychiatry (1969) 0.92
Molecular biology of neuroblastoma. Clin Transl Oncol (2007) 0.92
The efficacy of low-dose lithium: clinical, psychological and biological correlates. J Psychiatr Res (1989) 0.92
L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. Arch Gen Psychiatry (1974) 0.92
Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment. Am J Psychiatry (1982) 0.92
Thydrotropin releasing hormone: antagonism of pentobarbital in rodents. Life Sci (1974) 0.91
Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand (1988) 0.91
Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab (2009) 0.90
Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin). Arch Gen Psychiatry (1979) 0.90